Dikkopf-2, -3 and -4 Enhance Early Osteoblastic Differentiation in Mouse Mesenchymal Progenitor Cells and Stimulate Apoptosis in Osteoblastic Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The inhibitory effect of Dickkopf (Dkk)-1 on osteoblastic differentiation through blocking Wnt signaling has been well studied. However, the role of other members of the subfamily of Dkks remains unclear. We have examined the role of different Dkks on osteoblastic differentiation of mesenchymal progenitor cells and apoptosis of osteoblasts. Methods: Osteoblastic differentiation was induced by treatment of Wnt-3a with Dkks or vehicle in C3H10T1/2 cells and alkaline phosphatase (ALP) activity was measured. Serum deprivation induced apoptosis was performed with pre-treatment of Dkks or vehicle in MC3T3-E1 cells and methyl thiazolyl tetrazolium (MTT) assay was done. Results: Dkk-2 at low concentrations (5 and 20 nM) and Dkk-3, -4 at any concentrations (5 to 100 nM) significantly increased Wnt-3a-induced ALP activity, whereas Dkk-2 at high concentration (100 nM) significantly reduced. Treatment of Dkk-2, -3 and -4 at high concentration (100 nM) showed significant decreases of Wnt/β-catenin transcriptional activity,whereas no effects were seen at low concentration (20 nM). In parallel experiments, treatment of Dkk-1 showed robust dose dependent inhibition not only in ALP activity but also in Wnt/β-catenin transcriptional activity. Dkk-2, -3 and -4 increased serum deprivation-induced apoptosis in MC3T3-E1 mouse osteoblasts, while Dkk-1 had no effect. Conclusions: We found that unlike Dkk-1, Dkk-3 and -4 stimulated early osteoblastic differentiation at various concentrations regardless of their inhibitory effects on Wnt/β-catenin transcriptional activity at high concentration. Dkk-2 had a biphasic effect where the lower doses significantly increased ALP activity while the high dose was inhibitory. Dkk-2, -3 and -4stimulated osteoblast apoptosis whereas Dkk-1 had no effect. [Korean Journal of Bone Metabolism, 18(2): 101-110, 2011]
Abstract
Objectives: The inhibitory effect of Dickkopf (Dkk)-1 on osteoblastic differentiation through blocking Wnt signaling has been well studied. However, the role of other members of the subfamily of Dkks remains unclear. We have examined the role of different Dkks on osteoblastic differentiation of mesenchymal progenitor cells and apoptosis of osteoblasts. Methods: Osteoblastic differentiation was induced by treatment of Wnt-3a with Dkks or vehicle in C3H10T1/2 cells and alkaline phosphatase (ALP) activity was measured. Serum deprivation induced apoptosis was performed with pre-treatment of Dkks or vehicle in MC3T3-E1 cells and methyl thiazolyl tetrazolium (MTT) assay was done. Results: Dkk-2 at low concentrations (5 and 20 nM) and Dkk-3, -4 at any concentrations (5 to 100 nM) significantly increased Wnt-3a-induced ALP activity, whereas Dkk-2 at high concentration (100 nM) significantly reduced. Treatment of Dkk-2, -3 and -4 at high concentration (100 nM) showed significant decreases of Wnt/β-catenin transcriptional activity,whereas no effects were seen at low concentration (20 nM). In parallel experiments, treatment of Dkk-1 showed robust dose dependent inhibition not only in ALP activity but also in Wnt/β-catenin transcriptional activity. Dkk-2, -3 and -4 increased serum deprivation-induced apoptosis in MC3T3-E1 mouse osteoblasts, while Dkk-1 had no effect. Conclusions: We found that unlike Dkk-1, Dkk-3 and -4 stimulated early osteoblastic differentiation at various concentrations regardless of their inhibitory effects on Wnt/β-catenin transcriptional activity at high concentration. Dkk-2 had a biphasic effect where the lower doses significantly increased ALP activity while the high dose was inhibitory. Dkk-2, -3 and -4stimulated osteoblast apoptosis whereas Dkk-1 had no effect. [Korean Journal of Bone Metabolism, 18(2): 101-110, 2011]
참고문헌 (35)
- NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy, "Osteoporosis prevention, diagnosis, and therapy", JAMA, 285, pp.785~795 (2001)
- Bodine PV, "Wnt signaling and osteoblastogenesis", Rev Endocr Metab Disord, 7, pp.33~39 (2006)
- Glass DA, 2nd, "Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway", Curr Top Dev Biol, 73, pp.43~84 (2006)
- Krishnan V, "Regulation of bone mass by Wnt signaling", J Clin Invest, 116, pp.1202~1209 (2006)
- Deal C, "Potential new drug targets for osteoporosis", Nat Clin Pract Rheumatol, 5, pp.20~27 (2009)
- Hoeppner LH, "Wnt signaling as a therapeutic target for bone diseases", Expert Opin Ther Targets, 13, pp.485~496 (2009)
- Hay E, "Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway", J Biol Chem, 280, pp.13616~13623 (2005)
- Kawano Y, "Secreted antagonists of the Wnt signalling pathway", J Cell Sci, 116, pp.2627~2634 (2003)
- Hsieh JC, "A new secreted protein that binds to Wnt proteins and inhibits their activities", Nature, 398, pp.431~436 (1999)
- Semenov M, "SOST is a ligand for LRP5", LRP6 and a Wnt signaling inhibitor, 2005, pp.280, 26770~26775
- Mao B, "LDL-receptor-related protein 6 is a receptor for Dickkopf proteins", Nature, 411, pp.321~325 (2001)
- Fedi P, "Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling", J Biol Chem, 274, pp.19465~19472 (1999)
- Mao B, "Kremen proteins are Dickkopf receptors that regulate Wnt", beta-catenin signalling, 2002, pp.417, 664~667
- Krupnik VE, "Functional and structural diversity of the human Dickkopf gene family", Gene, 238, pp.301~313 (1999)
- Wu W, "Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt", beta-catenin signalling, 2000, pp.10, 1611~1614
- Li J, "Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia", Bone, 39, pp.754~766 (2006)
- Morvan F, "Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass", J Bone Miner Res, 21, pp.934~945 (2006)
- MacDonald BT, "Bone mass is inversely proportional to Dkk1 levels in mice", Bone, 41, pp.331~339 (2007)
- Fujita K, "Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF", Mol Cancer, 6, pp.71~ (2007)
- Goldring SR, "Eating bone or adding it: the Wnt pathway decides", Nat Med, 13, pp.133~134 (2007)
- Glantschnig H, "Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo", J Biol Chem, 285, pp.40135~40147 (2010)
- Heiland GR, "Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression", Ann Rheum Dis, 69, pp.2152~2159 (2010)
- Betts AM, "The application of target information and preclinical pharmacokinetic", pharmacodynamic modeling in predicting clinical doses of a Dickkopf-1 antibody for osteoporosis, 2010, pp.333, 2~13
- Gavriatopoulou M, "Dickkopf-1: a suitable target for the management of myeloma bone disease", Expert Opin Ther Targets, 13, pp.839~848 (2009)
- Yaccoby S, "Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo", Blood, 109, pp.2106~2111 (2007)
- Shibamoto S, "Cytoskeletal reorganization by soluble Wnt-3a protein signalling", Genes Cells, 3, pp.659~670 (1998)
- Galli LM, "Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3", Dev Dyn, 235, pp.681~690 (2006)
- Furlan F, "Proliferation, differentiation and apoptosis in connexin43-null osteoblasts", Cell Commun Adhes, 8, pp.367~371 (2001)
- Cho SW, "Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells", BONE, 44, pp.1069~1077, ELSEVIER SCIENCE INC
- van der Horst G, "Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells", J Bone Miner Res, 20, pp.1867~1877 (2005)
- Uren A, "Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling", J Biol Chem, 275, pp.4374~4382 (2000)
- 정윤석, "Effects of secreted frizzled-related protein 3 on osteoblasts in vitro", JOURNAL OF BONE AND MINERAL RESEARCH, 19, pp.1395~1402, AMER SOC BONE & MINERAL RES
- 조선욱, "Differential effects of secreted frizzled-related proteins (sFRPs) on osteoblastic differentiation of mouse mesenchymal cells and apoptosis of osteoblasts", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 367(2), pp.399~405, ACADEMIC PRESS INC ELSEVIER SCIENCE
- Bain G, "Activated beta-catenin induces osteoblast differentiation of C3H10T1", 2 cells and participates in BMP2 mediated signal transduction, 2003, pp.301, 84~91
- Rawadi G, "BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop", J Bone Miner Res, 18, pp.1842~1853 (2003)